14 hrs ago
Vivus acquires patent rights to Qsymia ingredient
Vivus has acquired a group of patents covering one of the main ingredients behind its weight loss drug Qsymia from Janssen Pharmaceuticals.
18 hrs ago
ViaCyte, Inc. Announces Signing of Rights Agreement with Janssen Research & Development LLC.
ViaCyte, Inc., a privately held regenerative medicine company announced that it has entered into a Rights Agreement with Janssen Research & Development LLC , one of the Janssen Pharmaceutical Companies of Johnson & Johnson.
Mon Aug 25, 2014
Here's Why Johnson & Johnson Is a Good Investment at 52-Week Highs
Johnson & Johnson is appreciating a decent time in 2014, liking 10% and beating the more extensive market so far.
Janssen Affiliate Cilag GmbH International Acquires Covagen AG
The opportunity was identified and facilitated through the Johnson & Johnson Innovation Center in .
Sat Aug 23, 2014
The San Diego Union-Tribune
Viacyte Partners with Janssen on Diabetes Therapy
San Diego's ViaCyte has received $20 million from a drug company to advance its stem cell-based therapy for Type 1 diabetes into human clinical trials.
New market study, "McNeil Iberica SLU in Consumer Health (Spain)", has been published
However, during 2013 the company showed a much lower profile in terms of new launches and television campaigns.
Fri Aug 22, 2014
Johnson & Johnson vs. Abbott Laboratories in the Battle for Emerging Market Turf
In 2010, emerging markets spent more than Germany, France, Italy, Spain and the U.K. combined.
SMS service for pregnant women
A new cellphone application, MomConnect, allows all pregnant women in the country to sign up for a free SMS service, which provides information and advice on pregnancy, and can be used to notify the Department of Health about poor services at clinics.
Thu Aug 21, 2014
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) Announces Signing Of Rights Agreement With
The agreement provides Janssen with a future right to evaluate a transaction related to the VC-01 combination product that ViaCyte is developing for type 1 diabetes.
Dow Movers: BA, JNJ
Our mission at Market News Video is to produce and distribute quality online videos about the stock markets and publicly traded companies.
Jeff Reeves's Strength in Numbers: This one stock sector can withstand all the 'bubble' talk
A beleaguered Johnson & Johnson has rebounded since January 2013, with its stock jumping 50% to beat the S&P 500.
Illumina Partners With Big PharmaTo Create New Genetic Tests For Cancer
I believe this is biology's century. I've covered science and medicine for Forbes from the Human Genome Project through Vioxx to the blossoming DNA technology changing the world today.
Tue Aug 19, 2014
Apple Inc. (AAPL), American Express Company (AXP), Johnson & Johnson...
Ken Fisher 's Fisher Asset Management filed a few weeks ago its Form 13F for the second quarter of 2014.
The Motley Fool
3 Reasons Hospira, Inc. Stock Could Rise
Last quarter, the maker of specialty injectable pharmaceuticals and medical devices reported that its revenue rose 11% year-over-year to $1.1 billion, while its adjusted earnings per share rose 31% to $0.72 per share.
Mon Aug 18, 2014
2 U.S. IPOs Planned For The Week Of August 18
Only two IPOs are expected to begin trading this week, both holdovers from last week that had originally been on the calendar for the week of August 4. The IPO market has begun its annual late-August hiatus, as last week's two deals trade just 1% from the IPO price and none are expected for next week.
TTIP: From Hot Tip to Oblivion?
Only a year ago, hopes were high of rapid progress towards a transatlantic trade deal that would boost the European and US economies - and ease conditions for drug firms on both sides of the ocean.
Apple Inc. (AAPL), Johnson & Johnson (JNJ), Pfizer Inc. (PFE) Among...
AQR Capital Management , managed by Cliff Asness , recently published its 13F filing with the U.S. Securities and Exchange Commission for the second quarter of 2014.
Product Defect News
Have You Been Injured By A Defective Hip Implant?
When your car is a lemon or is recalled for safety issues, you get it fixed at no cost at the dealership.
Interesting April 2015 Stock Options for Johnson & Johnson
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Johnson & Johnson .
The NOW Project 2014 update - a future proofing segmentation tool
The NOW Project is a unique segmentation that delivers insights into the hearts and minds of the people of RSA, enabling marketers to read change and position brands with a future facing perspective.